4C Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • 4C Medical's estimated annual revenue is currently $3.9M per year.(i)
  • 4C Medical's estimated revenue per employee is $112,000

Employee Data

  • 4C Medical has 35 Employees.(i)
  • 4C Medical grew their employee count by 0% last year.

4C Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director Clinical ResearchReveal Email/Phone
3
Sr. Director, R&DReveal Email/Phone
4
Founder, Chief Medical Officer & ChairmanReveal Email/Phone
5
Director Clinical ScienceReveal Email/Phone
6
Sr. ManagerReveal Email/Phone
7
Regulatory & Quality ManagerReveal Email/Phone
8
US Therapy Development ManagerReveal Email/Phone
9
Clinical Study and Safety ManagerReveal Email/Phone
10
Quality Assurance Quality ControlReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M48-35%N/AN/A
#2
$25.3M164-5%N/AN/A
#3
$2.2M225%N/AN/A
#4
$4.9M4621%$1.7MN/A
#5
$6.8M56-25%$4.1MN/A
#6
$3.9M350%N/AN/A
#7
$28.7M191-9%$1.1BN/A
#8
$0.4M6-25%N/AN/A
#9
$2.5M264%N/AN/A
#10
$1.5M18-40%N/AN/A
Add Company

What Is 4C Medical?

4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR). We are the first transcatheter MR therapy that directly addresses mitral regurgitation without replacing the native mitral valve, thus preserving the native mitral annulus and left ventricle. The device is positioned supra annular to the leaking native mitral valve to stop the leak from entering the left atrium. Its atrial only fixation ensures minimal disruption to critical cardiac structures within the left ventricle including the chordae tendineae and the left ventricular outflow tract. Our initial focus is to develop a novel therapy for mitral regurgitation (MR), and subsequently for tricuspid regurgitation (TR).

keywords:N/A

N/A

Total Funding

35

Number of Employees

$3.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

4C Medical News

2022-04-20 - Artrya : Quarterly Activity Report and Appendix 4C for Q3 FY22

He is a cardiologist and brings to the company significant experience in healthcare delivery and biotechnology. Artrya also established an...

2022-04-06 - 4C Medical Technologies Closes $35M Series C Financing

Jeff Chambers, Founder and Chairman of the Board, 4C Medical is a medical device company developing minimally invasive technologies for...

2022-03-30 - 4C Medical Technologies Completes $35 Million Series C ...

About 4C Medical Technologies, Inc. 4C Medical is a medical device company developing minimally invasive technologies for structural heart...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M353%N/A
#2
$7.8M36-10%N/A
#3
$4.7M379%N/A
#4
$4.8M40-7%N/A
#5
$8.6M40-13%N/A